Robotic Catheters And Digital Surgery Will Boost Adoption

Published
03 Apr 25
Updated
15 Aug 25
AnalystConsensusTarget's Fair Value
US$4.50
36.0% undervalued intrinsic discount
15 Aug
US$2.88
Loading
1Y
44.0%
7D
8.3%

Author's Valuation

US$4.5

36.0% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on01 May 25
Fair value Decreased 1.32%

Shared on24 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Increased 1.33%

AnalystConsensusTarget has increased shares outstanding growth rate from 0.0% to 0.0%.